Publisher Correction: Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma

Brecht Decraene; Yihan Yang; Frederik De Smet; Abhishek D Garg; Patrizia Agostinis; Steven De Vleeschouwer

doi:10.1038/s41435-022-00187-3

Publisher Correction: Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma

Genes Immun. 2022 Dec;23(8):244. doi: 10.1038/s41435-022-00187-3.

Authors

Brecht Decraene^#^{1

2

3}, Yihan Yang^#^{1

4

5}, Frederik De Smet², Abhishek D Garg⁶, Patrizia Agostinis^#^{4

5}, Steven De Vleeschouwer^#^{7

8

9}

Affiliations

¹ Research Group Experimental Neurosurgery and Neuroanatomy, Department of Neurosciences, KU Leuven, Leuven, Belgium.
² Laboratory for Precision Cancer Medicine, Translational Cell and Tissue Research Unit, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
³ Department of Neurosurgery, University Hospitals Leuven, Leuven, Belgium.
⁴ Laboratory of Cell Death Research & Therapy, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
⁵ VIB Center for Cancer Biology Research, Leuven, Belgium.
⁶ Laboratory of Cell Stress & Immunity (CSI), Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium.
⁷ Research Group Experimental Neurosurgery and Neuroanatomy, Department of Neurosciences, KU Leuven, Leuven, Belgium. steven.devleeschouwer@uzleuven.be.
⁸ Department of Neurosurgery, University Hospitals Leuven, Leuven, Belgium. steven.devleeschouwer@uzleuven.be.
⁹ Leuven Brain Institute (LBI), KU Leuven, Leuven, Belgium. steven.devleeschouwer@uzleuven.be.

^# Contributed equally.

No abstract available

Publication types

Published Erratum